报价延迟最少15分钟:2026/05/15 17:08 EDT
盘后时段
|
||||
|
1.97 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.97
|
|
|
| 价值评估 |
|
盈利(现时/预测)
0.43/0.53
|
|
企业价值
162.23M
|
| 资产负债 |
|
每股账面净值
-1.85
|
| 现金流量 |
|
现金流量率
0.46
|
| 损益表 |
|
收益
192.22M
|
|
每股收益
5.95
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements. |
